Status:
COMPLETED
Impact of Opportunistic Salpingectomy on Ovarian Reserve in Patients Undergoing Laparoscopic Hysterectomy
Lead Sponsor:
CHA University
Conditions:
Benign Uterine Disease
Eligibility:
FEMALE
19-52 years
Phase:
PHASE3
Brief Summary
Recently, many gynecologic oncologists proposed that surgeons should consider opportunistic salpingectomy to prevent ovarian cancer for all patients undergoing hysterectomy for benign disease. However...
Eligibility Criteria
Inclusion
- women who were planning to undergo laparoscopic hysterectomy for benign uterine diseases
- women aged between 19 and 52 years
- women with regular menstruation (defined as the duration of menstrual cycle between 21 and 45 days)
- women who were appropriated medical status for laparoscopic surgery
Exclusion
- any ovarian cysts requiring ovarian surgery
- any suspicious findings of malignant diseases
- history of prior salpingectomy or salpingo-oophorectomy
- pregnant or menopausal status
- preoperative serum anti-Müllerian hormone (AMH) \< 0.30 ng/mL
- use of hormonal treatments in the three months before surgery
- any other endocrine disease (such as uncontrolled thyroid dysfunction, hyperprolactinemia, or Cushing syndrome)
- an inability to understand and provide written informed consent.
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT01893086
Start Date
June 1 2013
End Date
July 1 2015
Last Update
January 28 2016
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Keimyung University School of Medicine
Daegu, South Korea, 700-712
2
Kangbuk Samsung Hospital
Seoul, South Korea, 110-746
3
CHA Gangnam Medical Center
Seoul, South Korea, 135-081